ASIATICLAB Stock Overview
Manufactures and markets pharmaceutical products in Bangladesh and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Asiatic Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳33.90 |
| 52 Week High | ৳79.40 |
| 52 Week Low | ৳22.00 |
| Beta | 0 |
| 1 Month Change | 12.25% |
| 3 Month Change | -6.35% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 54.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| ASIATICLAB | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -3.7% | 5.0% | 2.1% |
| 1Y | n/a | -24.3% | -21.0% |
Return vs Industry: Insufficient data to determine how ASIATICLAB performed against the BD Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ASIATICLAB performed against the BD Market.
Price Volatility
| ASIATICLAB volatility | |
|---|---|
| ASIATICLAB Average Weekly Movement | 8.2% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in BD Market | 9.0% |
| 10% least volatile stocks in BD Market | 3.5% |
Stable Share Price: ASIATICLAB's share price has been volatile over the past 3 months compared to the BD market.
Volatility Over Time: ASIATICLAB's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | n/a | Monir Ahmed | asiaticpharma.com |
Asiatic Laboratories Limited manufactures and markets pharmaceutical products in Bangladesh and internationally. The company offers products in the categories of antihistamines and respiratory care; cardiac and eye care; antibiotics, antifungals and antiprotozoals; vitamins and minerals; antiulcerants and antiemetics; dermatological products; antipsychotics and tranquilizers; and non-steroidal anti-inflammatory drugs. It distributes its products through sales distribution centers and a store.
Asiatic Laboratories Limited Fundamentals Summary
| ASIATICLAB fundamental statistics | |
|---|---|
| Market cap | ৳4.15b |
| Earnings (TTM) | ৳268.56m |
| Revenue (TTM) | ৳1.47b |
0.0x
P/E Ratio0.0x
P/S RatioIs ASIATICLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASIATICLAB income statement (TTM) | |
|---|---|
| Revenue | ৳1.47b |
| Cost of Revenue | ৳835.39m |
| Gross Profit | ৳637.39m |
| Other Expenses | ৳368.84m |
| Earnings | ৳268.56m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ASIATICLAB perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yieldn/a
Payout RatioDoes ASIATICLAB pay a reliable dividends?
See ASIATICLAB dividend history and benchmarks| Asiatic Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | Nov 21 2024 |
| Dividend Pay Date | Jan 19 2025 |
| Days until Ex dividend | 31 days |
| Days until Dividend pay date | 28 days |
Does ASIATICLAB pay a reliable dividends?
See ASIATICLAB dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 07:00 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2022/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Asiatic Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|